Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
Influenza viruses cause annual epidemics and occasional pandemics. The high diversity of viral envelope proteins permits viruses to escape host immunity. Therefore, the development of a universal vaccine and broadly neutralizing antibodies (bnAbs) is essential for controlling various mutant viruses....
Main Authors: | Mrityunjoy Biswas, Tatsuya Yamazaki, Joe Chiba, Sachiko Akashi-Takamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/3/424 |
Similar Items
-
B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes
by: Sanjeev Kumar, et al.
Published: (2024-02-01) -
Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01) -
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors
by: Luigi Liguori, et al.
Published: (2022-11-01) -
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
by: Pardis Mokhtary, et al.
Published: (2022-08-01) -
Monoclonal antibodies: From magic bullet to precision weapon
by: Hassan Aboul-Ella, et al.
Published: (2024-10-01)